Diagnosis
Home urine tests could detect breast cancer, endometriosis and PCOS

“Game-changing” home urine tests to detect early stage breast cancer are being developed in Wales, alongside similar work on endometriosis and polycystic ovary syndrome.
Researchers said they hope to have a prototype kit within the next year to detect early stage breast cancer using a lateral flow urine sample. Lateral flow tests are simple strip-based devices used during the Covid-19 pandemic.
A similar test is now also being explored for endometriosis and polycystic ovary syndrome, or PCOS, which in the long term could help reduce diagnostic waiting times.
The developments form part of wider work on women’s health in Wales, with women’s health hubs being rolled out across all parts of the country.
The research is being led by Prof Luis Mur at Aberystwyth University, who said key changes could be identified in urine to detect breast cancer “with a high degree of accuracy” and that new at-home tests were being developed to complement existing diagnostic tools.
“We’ve found very important changes in urine to tell you’ve got breast cancer, and even [which] stage of breast cancer,” he said.
“We’re building little kits that are based on urine that actually allow you to go to your GP and have it done, or even do it at home.”
Mur said it could take about 18 months to develop the lateral flow prototypes, followed by a further three to five years of testing to confirm accuracy.
“We need to have 90 per cent accuracy or greater, at the moment we’ve got it, but we need to make sure we get that with the kit itself,” he said.
He added that researchers were now applying the same approach to detect endometriosis and PCOS, where “diagnoses are very poor and also very delayed”.
The breast cancer testing kits are among projects funded by the Welsh government’s £75m investment in women’s health research, as part of the women’s health plan.
Dr Helen Munro, clinical lead for women’s health in Wales, said one of the goals of the Women’s Health Research Centre was to bring research findings, such as the work at Aberystwyth University, into clinical practice “in a timely way”.
“Currently there’s evidence to suggest it takes 17 years for evidence to get into practice, Munro said.
“But what we’re doing in Wales is working really closely with our academic universities and health boards to shorten that gap.”
The 10-year women’s health plan in Wales, published in December 2024, also set out ambitions for women’s health hubs in each health board.
By the end of this month each health board will have at least one hub serving part of their community, though Munro said “each will look different”.
In west and mid Wales, Hywel Dda health board has split the region into seven GP clusters, each of which will have a women’s health service.
GPs in each cluster have been trained to provide menopause and contraceptive care and can take referrals from other surgeries, bringing specialist care closer to home.
“We’re aiming to see a reduction in referrals into secondary care, with women referred into the hub in a timelier fashion,” said Dana Scott, who is leading the women’s health plan for Hywel Dda.
Dr Lauren Thomas, a sexual health doctor who has been training GPs in more remote areas to fit coils and contraceptive implants, said ultrasound biopsies would also be available in each county.
“As a GP I see women wait months and months and months to see gynae [specialists] because obviously the secondary care service has to prioritise suspected cancer cases,” she said.
“Women are left with pelvic pain or [with] endometriosis waiting a long time for discussions, investigations and treatments that they could access in a community-based clinic, and hopefully we’ll be able to bring that to women moving forward.”
Munro said all hubs had been asked to deliver on three priority areas: menopause care, contraception and pelvic health.
Sarah Murphy MS, minister with responsibility for women’s health, said each health board was “starting from different places”.
She said: “They’re trying to fill in the gaps, breaking down the barriers for each of those locations and communities.
“But as we go forward there’ll be an evaluation and we’ll spread that good practice across Wales.”
Diagnosis
WHO launches AI tool for reproductive health information

The World Health Organization (WHO) has launched an AI tool in beta to help policymakers, experts and healthcare professionals access sexual and reproductive health information faster.
Called ChatHRP, the tool was created by WHO’s Human Reproduction Programme and draws only on verified research and guidance collected by HRP and WHO.
It uses natural language processing and retrieval-augmented generation to produce referenced content and cut the time spent searching through documents across different platforms and databases.
WHO said ChatHRP also has multilingual capabilities and low-bandwidth functionality to support use in a wide range of settings.
The beta-testing phase is aimed at a broad professional audience, including policymakers, healthcare workers, researchers and civil society groups.
WHO said the tool can help users quickly access up-to-date evidence, find sources for academic work and verify information on sexual and reproductive health and rights.
Examples of questions it can answer include the latest violence against women data in Oceania for women aged 15 to 49, recommendations on managing diabetes during pregnancy, and whether PrEP and contraception can be used at the same time. PrEP is medicine used to reduce the risk of getting HIV.
WHO added that the system will be updated regularly as new HRP materials are published and includes a feedback loop so users can flag gaps in the information provided.
The launch comes amid wider concern about misinformation in sexual and reproductive health.
A 2025 scoping review found that misinformation in digital spaces is a systemic issue that can undermine human rights, reinforce discriminatory social norms and exclude marginalised voices.
The review also said misinformation can affect health systems by shaping provider knowledge and practice, disrupting service delivery and creating barriers to equitable care.
WHO said ChatHRP is intended to give users streamlined access to reliable information as a counter to “algorithms, opinions, or misinformation”.
Menopause
AI maps how reproductive organs age differently during menopause
Pregnancy
Early miscarriage care could prevent 10,000 pregnancy losses a year, study finds
Entrepreneur2 weeks agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
News1 week agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Fertility3 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Menopause3 weeks agoMore research needed to understand link between brain fog and menopause, expert says
Mental health2 weeks agoLifting weights shows mental health and cognitive benefits in older women, study finds
News4 weeks agoSelf-employment linked to better cardiovascular health outcomes in Hispanic women
Entrepreneur3 weeks agoFlora Fertility closes US$5m seed round
Menopause2 weeks agoResistance training has preventative effects in menopause, study finds
















2 Comments